The new system allows Chronix to display screen and analyze 25-occasions more genomes each month far more cost-effectively than was feasible with older strategies. It has reduced enough time needed to screen a genome by about 80 percent, while improving reproducibility of the full total results. The new program has recently enhanced the performance of Chronix’s initial tests for breast and prostate cancer, and is expected to accelerate development and commercialization efforts across the board. Usage of this advanced mass sequencer will enable us to speed-up generation of the databases and related information that are prerequisites for advancement and commercialization of our apoptotic DNA biomarker technology, noted Dr. Howard Urnovitz, CEO of Chronix. The Chronix technology has shown early utility in a number of cancers and in CNS illnesses such as multiple sclerosis and BSE.Kaiser Family members Foundation. Kaiser Health Information, an editorially independent information service, is an application of the Kaiser Family members Foundation, a nonpartisan healthcare policy research corporation unaffiliated with Kaiser Permanente.. Anxiety disorders associated with thyroid disease, respiratory disease, arthritis and migraine headaches Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraines, according to a written report in the October 23 problem of Archives of Internal Medicine.